Eyal Arieli

Director/Board Member at MERCHAVIA HOLDINGS AND INVESTMENTS LTD

62 year

Consumer Services

Finance

Health Technology

Profile

Eyal Arieli is currently working as the Chief Operating Officer & Chief Financial Officer at Precise Bio, Inc. and as an Independent External Director at Merchavia Holdings & Investments Ltd.
He completed his undergraduate degree at The Hebrew University of Jerusalem and his MBA at Bar-Ilan University.

Eyal Arieli active positions

Companies	Position	Start
MERCHAVIA HOLDINGS AND INVESTMENTS LTD	Director/Board Member	2020-06-06
Precise Bio, Inc. Precise Bio, Inc. Pharmaceuticals: MajorHealth Technology Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.	Director of Finance/CFO	-

All active positions of Eyal Arieli

Training of Eyal Arieli

The Hebrew University of Jerusalem	Undergraduate Degree
Bar-Ilan University	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eyal Arieli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MERCHAVIA HOLDINGS AND INVESTMENTS LTD	Finance

Private companies	1
Precise Bio, Inc. Precise Bio, Inc. Pharmaceuticals: MajorHealth Technology Precise Bio, Inc. is a regenerative medicine company that specializes in bio-printed tissues and organs for patients in ophthalmology. The company is based in Winston-Salem, NC. The company's main focus is on developing a bio-printed cornea graft to replace donor corneas. The company is also working on a 3D cardiac tissue "patch" for post myocardial infarction implant to retrieve cardiac muscle viability and functionality. Precise Bio uses an integrated 3D printing and tissue-engineering platform to produce scalable, repeatable bio-fabricated organs from the patients' own cells. The company was founded in 2015 by Anthony Atala, Aryeh Batt, Shay Soker. Aryeh Batt has been the CEO since 2015.	Health Technology